How to read a pre-IPO opportunity in 2026

How to read a pre-IPO opportunity in 2026

The 2026 IPO wave has made pre-IPO investing a dinner-party topic. Cerebras priced the largest US tech IPO since Uber in May (CNBC, 2026-05-13). SpaceX followed with the largest IPO on record, and OpenAI and Anthropic have both confidentially filed (IG, 2026-05-20). Unsurprisingly, accredited investors are now being offered shares, units and SPV interests in private companies at a pace not seen since 2021.

Some of those offers are good. Many are not. This essay is a practical framework for telling the difference. It is educational, not a recommendation, and it applies to any manager, including us.

1. Understand what you are actually buying

The first question is not the company. It is the instrument.

• Direct primary shares are newly issued by the company in a funding round. They usually come with the round's negotiated rights.
• Direct secondary shares are bought from an existing holder, often an employee or early investor. They are frequently common stock, which ranks below preferred stock in a liquidation.
• SPV interests are units in a special purpose vehicle that itself holds shares. You own a piece of the vehicle, not the company.
• Forward contracts or synthetic exposure promise the economic value of shares at a later date without transferring them now. These carry counterparty and enforceability risks and deserve extra scrutiny.

Ask for the exact share class, the chain of ownership from you to the company, and whether the company has approved the transfer. Many private companies restrict transfers and hold rights of first refusal.

2. Read secondary pricing in context

Private share prices are not quoted continuously, so a single number can mislead.

A useful anchor is the last primary round price. Secondary trades are often quoted as a premium or discount to it. Industry sources suggest common stock commonly trades at a discount to the latest preferred price, with ranges of 10 to 40 percent cited depending on company and conditions, while the most sought-after names can trade at par or above (Augment, 2026; ESO Fund, 2026). Forge has reported periods in which platform trades no longer carried a premium to last-round prices (TechCrunch, via Forge data).

When you see a price, ask:

• Premium or discount to which round, and when was that round?
• Is the price for common or preferred?
• Does it include the SPV's fees and carry, or are those on top?
• What have recent trades in the same company printed, and on how much volume?

A modest discount on a stale round can be expensive. A premium on a recent round can be fair. Context is everything.

3. Information rights are usually thin

Investors in primary rounds often receive financial statements and other information. Secondary buyers and SPV investors frequently receive very little. You may not see audited financials, capitalisation tables or board materials, and you may learn about major events from the press.

Ask what you will receive, how often and from whom. If the answer is "the company does not share information with secondary holders", price that in. It is common. It is also a real risk.

4. Know the lock-ups before and after the IPO

Liquidity in pre-IPO investing arrives later than most people expect.

Before a listing, you generally cannot sell without company approval and a willing buyer. At the IPO itself, existing shareholders are typically subject to a lock-up agreement with the underwriters, often around 180 days, during which they cannot sell (SEC Investor.gov, "Lock-up agreements"). SPVs may add their own distribution timing on top, and some managers distribute shares in kind while others sell and distribute cash.

Also remember that IPOs can be delayed or withdrawn. Cerebras publicly filed in 2024, saw its timeline slip amid a CFIUS review, and formally withdrew in October 2025 before returning to market in 2026 (Reuters via KFGO, 2024-10-09; CNBC, 2025-10-03). A holding period of years, not months, is the planning assumption.

5. Look hard at the SPV

SPVs are the most common route for individual investors into late-stage companies. They are also where most avoidable problems live.

Questions worth asking:

• Who is the manager, and what is their track record with this company? Do they have a direct relationship or are they several layers removed?
• Is it a single SPV or an SPV holding another SPV? Each layer adds fees, legal complexity and transfer risk. Some companies have publicly objected to unauthorised multi-layer vehicles.
• Is the underlying position verified? Ask for evidence that the vehicle actually holds the shares, and how title was transferred.
• What happens at the IPO? Distribution in kind or sale? Who decides, and when?
• What are the reporting and audit arrangements?

We apply the same checklist to any vehicle we participate through.

6. Add up all the fees

Pre-IPO products can carry several layers of cost: placement fees or upfront loads, annual management fees, carried interest on gains, administration and legal fees, and sometimes a markup embedded in the share price. Individually they may look modest. Together they can consume a meaningful share of any gain.

Ask for a full fee schedule, including fees at the underlying vehicle if there is one, and model the net outcome under a range of exit valuations, including one where the company is flat or down.

7. Weigh the real risks

The risks in pre-IPO investing are substantial and should be stated plainly:

• Valuation risk. Private valuations can fall. Stripe's valuation was cut in the 2022 downturn before recovering (CNBC, 2026-02-24). Many companies do not recover.
• Illiquidity. You may be unable to sell for years.
• Concentration. A single-company position carries company-specific risks that diversification would otherwise reduce. Cerebras's 2024 filing disclosed that one customer accounted for 87 percent of first-half revenue (Cerebras Form S-1, SEC, 2024).
• Post-IPO volatility. Strong debuts can reverse. Cerebras shares gave back part of their first-day gain in subsequent trading (Yahoo Finance, 2026-05).
• Structural and counterparty risk. SPV and forward structures depend on the integrity of intermediaries.
• Total loss. Private companies can and do fail.

A short checklist

Before committing, you should be able to answer:

1. What instrument am I buying, and what share class sits underneath?
2. What price am I paying relative to the last round and to recent trades?
3. What information will I receive?
4. How many layers sit between me and the company, and are they verified?
5. What are the total fees, all in?
6. When and how could I get liquidity, and what if the IPO slips?
7. What would I lose if the company were marked down by half?

If any answer is unclear, the opportunity is not ready for you, however compelling the company.

Where CrossWork fits

We manage a diversified approach to late-stage and pre-IPO technology through CrossWork Midas II, sourced through an advisory board of former operators and offered by invitation. We think a manager should welcome every question above. Verified investors can review our structures, terms and detailed performance in the CrossWork portal.

---

Sources

• CNBC, "Cerebras prices IPO above expected range" (2026-05-13).
• IG, "SpaceX, OpenAI, Anthropic: upcoming IPOs to watch in 2026" (2026-05-20).
• Augment, "Secondary market pricing: valuing private company shares" (2026).
• ESO Fund, "Secondary sales: how to sell private company shares" (2026).
• TechCrunch, "You can now get startup shares on the cheap" (Forge data, undated in search result).
• SEC Investor.gov, "Lock-up agreements" (investor bulletin).
• Reuters via KFGO, "Cerebras likely to postpone IPO due to CFIUS review delay" (2024-10-09).
• CNBC, "AI chipmaker Cerebras withdraws IPO" (2025-10-03).
• Cerebras Systems, Form S-1, SEC EDGAR (2024).
• CNBC, "Stripe valued at $159 billion after tender offer" (2026-02-24).
• Yahoo Finance, "Cerebras stock slides after near-70% surge" (2026-05).

Past performance is not indicative of future results. This is not an offer; offering documents govern. Detailed performance is available to verified investors in the CrossWork portal. This is not investment advice.